InMode (INMD) Non Operating Investment Income (2024 - 2025)

InMode (INMD) posted quarterly Non Operating Investment Income of $1000.0 for Q4 2025, up 133.33% year-on-year from $428.57 in Q4 2024, and up 133.33% on a QoQ basis from -$3000.0 in Q4 2024.

InMode (INMD) Non Operating Investment Income (2024 - 2025) Analysis & Trends

InMode (INMD) has reported Non Operating Investment Income for 2 consecutive years, with $1000.0 the latest figure, recorded in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 InMode 981,130.50 -479.15 Mn 61.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,000.00
Dec 31, 2025 1,000.00
Dec 31, 2024 -3,000.00
Dec 31, 2024 -3,000.00